280 related articles for article (PubMed ID: 8012678)
1. The polycystic ovary syndrome. 1. Pathogenesis.
White MC; Turner EI
Br J Hosp Med; 1994 Feb 16-Mar 1; 51(4):167-74. PubMed ID: 8012678
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome.
Chihal HJ; Baudier MM
Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
[TBL] [Abstract][Full Text] [Related]
3. Hirsutism and polycystic ovary syndrome.
Givens JR; Goodman RC
Hosp Pract (Off Ed); 1986 Oct; 21(10A):81-4, 87-9, 93-4 passim. PubMed ID: 3095345
[No Abstract] [Full Text] [Related]
4. Pathogenesis of polycystic ovarian disease.
James R; Givens MD
Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
[No Abstract] [Full Text] [Related]
5. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.
Yao LQ; Kuang JQ; Feng YJ; Yang DZ; Li L; Xu CJ
Fertil Steril; 2006 Mar; 85(3):805-8. PubMed ID: 16500371
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
Rossmanith WG; Keckstein J; Spatzier K; Lauritzen C
Gynakol Rundsch; 1991; 31 Suppl 2():333-5. PubMed ID: 1790971
[No Abstract] [Full Text] [Related]
8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
9. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
11. The polycystic ovary syndrome--a medical condition but also an important psychosocial problem.
Eggers S; Kirchengast S
Coll Antropol; 2001 Dec; 25(2):673-85. PubMed ID: 11811299
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
[TBL] [Abstract][Full Text] [Related]
13. Mood and sexual function in polycystic ovary syndrome.
Janssen OE; Hahn S; Tan S; Benson S; Elsenbruch S
Semin Reprod Med; 2008 Jan; 26(1):45-52. PubMed ID: 18181082
[TBL] [Abstract][Full Text] [Related]
14. Metformin for the treatment of the polycystic ovary syndrome.
Barbieri RL; Gargiulo AR
Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
[TBL] [Abstract][Full Text] [Related]
15. [Hirsutism and androgenic menstrual cycle irregularities].
Carol W; Wilke I
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):153-7. PubMed ID: 2058208
[No Abstract] [Full Text] [Related]
16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
17. The use of metformin as first line treatment in polycystic ovary syndrome.
Abbas M; Gannon M
Ir Med J; 2008 Feb; 101(2):51-3. PubMed ID: 18450250
[TBL] [Abstract][Full Text] [Related]
18. [Polycystic ovary syndrome I. Clinical presentation and treatment].
Ovesen PG; Møller N; Greisen S; Ingerslev HJ
Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
[TBL] [Abstract][Full Text] [Related]
19. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
Vulkov I; Georgiev Ch
Akush Ginekol (Sofiia); 1982; 21(3):238-43. PubMed ID: 6289691
[No Abstract] [Full Text] [Related]
20. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
Ushiroyama T; Ikeda A; Sakai M; Hosotani T; Suzuki Y; Tsubokura S; Ueki M
J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]